Cargando…
Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unr...
Autores principales: | Xu, Lieqiang, Cheng, Juanjuan, Lu, Jieyi, Lin, Guoshu, Yu, Qiuxia, Li, Yucui, Chen, Jiannan, Xie, Jianhui, Su, Ziren, Zhou, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692208/ https://www.ncbi.nlm.nih.gov/pubmed/36438835 http://dx.doi.org/10.3389/fphar.2022.964593 |
Ejemplares similares
-
Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System
por: Li, Minhua, et al.
Publicado: (2022) -
Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
por: Xu, Lieqiang, et al.
Publicado: (2021) -
Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model
por: Li, Qiaoping, et al.
Publicado: (2021) -
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics
por: Yu, Qiuxia, et al.
Publicado: (2022) -
Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review
por: Sun, Yue, et al.
Publicado: (2019)